首页> 美国卫生研究院文献>Journal of Clinical Medicine >Validity of Clinical Symptoms Score to Discriminate Patients with COVID-19 from Common Cold Out-Patients in General Practitioner Clinics in Japan
【2h】

Validity of Clinical Symptoms Score to Discriminate Patients with COVID-19 from Common Cold Out-Patients in General Practitioner Clinics in Japan

机译:临床症状的有效性分数以区分Covid-19患者在日本的全科医生诊所中的普通冷外诊断

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: Coronavirus disease 2019 (COVID-19) has spread worldwide, including Japan. However, little is known about the clinical symptoms which discriminate between COVID-19 and non-COVID-19 among outpatients in general practitioner clinics, which is important for efficient case detection. The aim of this study was to investigate the clinical symptoms to discriminate between COVID-19 and non-COVID-19 cases among outpatients in general practitioner clinics during the second wave of the COVID-19 pandemic in Japan in August 2020. Methods: The records of 360 patients who visited a clinic with suspicion of infectious disease and underwent COVID-19 PCR test between 1 and 14 August 2020 were used. The patients filled out a questionnaire on possible clinical symptoms and transmission routes. Multivariate logistic regression was used to investigate the association between clinical symptoms and COVID-19 status. Results: COVID-19-positive patients were 17 (4.7%). Multiple logistic regression analyses showed that anosmia (odds ratio (OR), 25.94 95% confidence interval (CI), 7.15–94.14; p < 0.001), headache (OR, 3.31 95% confidence interval (CI), 0.98–11.20; p = 0.054), sputum production (OR, 3.32 CI, 1.01–10.90; p = 0.048) and history of visiting an izakaya or bar (OR, 4.23 CI, 0.99–18.03; p = 0.051) were marginally significantly associated withbeing COVID-19 positive. This model showed moderate predictive power (area under receiver operating characteristic curve = 0.870 CI, 0.761 to 0.971). Conclusions: We found that anosmia, headache, sputum production, history of visiting an izakaya or bar were associated with COVID-19, which can be used to detect patients with COVID-19 in out-patient clinics in Japan. The findings of this study need to be verified in other clinics and hospitals in Japan and other countries with universal healthcare coverages.
机译:目的:2019年冠状病毒疾病(Covid-19)在包括日本在内的全球范围内传播。然而,关于临床症状的临床症状几乎是众所周知的,这些症状在一般的医生诊所的门诊患者中歧视Covid-19和非Covid-19,这对于有效的案例检测是重要的。本研究的目的是探讨临床症状,以在2020年8月在日本Covid-19大流行病的第二波在日本的二手诊所间隔诊断临床诊所之间的临床症状。方法:记录使用360名患者患有感染性疾病的诊所和14岁至8月2020年8月的Covid-19 PCR试验。患者在可能的临床症状和传输路线上填写了调查问卷。多变量逻辑回归用于探讨临床症状与Covid-19状态之间的关联。结果:Covid-19阳性患者17(4.7%)。多元逻辑回归分析表明,Anosmia(OTA比(或),25.94 95%置信区间(CI),7.15-94.14; p <0.001),头痛(或3.31 95%置信区间(CI),0.98-11.20; p = 0.054),痰液生产(或3.32 CI,1.01-10.90; p = 0.048)和访问伊扎亚岛或酒吧的历史(或4.23 ci,0.99-18.03; p = 0.051)与Covid-19有明显明显相关积极的。该模型显示了适度的预测力(接收器下的区域操作特性曲线= 0.870ci,0.761至0.971)。结论:我们发现Anosmia,头痛,痰生产,访问Izakaya或Bar的历史与Covid-19有关,可用于检测日本外科诊所的Covid-19患者。本研究的调查结果需要在日本和其他具有普遍医疗保健覆盖范围内的其他诊所和医院核实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号